EGFR‐Targeting IgG1 Antibody Enhances NK Cell‐Mediated Tumor Killing in KRAS‐Mutant Pancreatic Cancer
Ruoxi Xiao, Xiaoxiao Li, Ping Li, Junjin Wang, Xiaoyuan Sun, Chenyang Zhao, Zimin Liu, Ruining Gong, Minghan Ren, Ke Lei, He Ren · 2026
Read EGFR‐Targeting IgG1 Antibody Enhances NK Cell‐Mediated Tumor Killing in KRAS‐Mutant Pancreatic Cancer by Ruoxi Xiao, Xiaoxiao Li, Ping Li, Junjin Wang, Xiaoyuan Sun, Chenyang Zhao, Zimin Liu, Ruining Gong, Minghan Ren, Ke Lei, He Ren (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13291551.txt.
Description
An antibody can turn killer immune cells on pancreas tumors. Ruoxi Xiao leads a 2026 study of KRAS-mutant pancreatic cancer. Such tumors shrug off growth signal blockers. The mutant gene keeps growth switched on below the blocker.
Antibodies of one class can still flag tumor cells. Killer cells then destroy the flagged cells directly. The team paired nimotuzumab with added killer cells. Dish, ball culture, and mouse models all showed strong killing. Killer cells woke fully and homed to tumors. Tumor EGFR levels predicted how well it worked. KRAS status did not block the effect. Flag-based killing thus bypasses the mutant switch.
Catalog record
| CREATOR | Ruoxi Xiao, Xiaoxiao Li, Ping Li, Junjin Wang, Xiaoyuan Sun, Chenyang Zhao, Zimin Liu, Ruining Gong, Minghan Ren, Ke Lei, He Ren |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57648 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |